ArticleMolecular oncology2026

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma.

Kamila J Bienkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.